Stock listing

NASDAQ:BOLD Audentes Therapeutics Inc Stock

Follow Audentes Therapeutics Inc into a list and get an email when it puts out news.

Last close · NASDAQ:BOLD

$59.97 USD

Close on Jan 16, 2020 · No longer trades

Jul 20, 2016 to last close +296.4% · weekly closes, Jul 20, 2016 – Jan 16, 2020
Lowest – highest close
$14.11 – $60.00 USDSince Jul 20, 2016 · lowest Sep 14, 2016 · highest Jan 6, 2020

Delisted NASDAQ:BOLD no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:BOLD
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Audentes Therapeutics Inc on 6ix

Decks
10 decks · latest Oct 9, 2019

Events

QuarterResultsShare move
Quarter to Sep 30, 2026Nov 10, 2026 · Before open−0.4%
Quarter to Jun 30, 2026Aug 7, 2026−0.7%
Quarter to Mar 31, 2026May 8, 2026 · Before open−5.9%
Quarter to Dec 31, 2025Mar 26, 2026−1.8%
Quarter to Sep 30, 2025Nov 5, 2025 · Before open−3.1%
Quarter to Jun 30, 2025Aug 5, 2025 · Before open−1.7%
Quarter to Mar 31, 2025May 9, 2025 · Before open−4.0%
Quarter to Dec 31, 2024Mar 27, 2025−1.3%
Quarter to Sep 30, 2024Nov 7, 2024 · After close+5.4%
Quarter to Jun 30, 2024Aug 12, 2024 · After close+2.8%
All 12 quarters
QuarterResultsShare move
Quarter to Mar 31, 2024May 13, 2024 · Before open+10.8%
Quarter to Dec 31, 2023Feb 28, 2024

Open Events

Decks

DeckKindSlidesDate
24th International Annual Congress of the World Muscle Society (WMS) Annual Meeting 2019Conference24 slidesOct 9, 2019
Technical Presentation (May 2019)Technical29 slidesMay 1, 2019
Technical Presentation (October 2018)Technical20 slidesOct 5, 2018
Technical Presentation (May 2018)Technical16 slidesMay 16, 2018
Technical Presentation (January 2018)Technical21 slidesJan 4, 2018
Investor Presentation (September 2017)Investor deck33 slidesSep 27, 2017
Technical Presentation (September 2017)Technical23 slidesSep 27, 2017
Cowen 37th Annual Health Care Conference 2017Conference36 slidesMar 7, 2017
Investor Presentation (November 2016)Investor deck34 slidesNov 29, 2016
Investor Presentation (September 2016)Investor deck34 slidesSep 28, 2016

Open Decks

Cap table

Built by 6ix from Audentes Therapeutics Inc’s releases

Common shares
23,108,935
Fully diluted
23,108,935

Fully diluted

LineShares
Common shares23,108,935

Share count over time

CountShares
Nov 22, 202623,108,935

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Samuel D Isaly
Other companies: Synlogic Inc (Director · Aug 28, 2017 – Aug 28, 2017 · Past); Alpine Immune Sciences Inc (Director · Jul 24, 2017 – Jul 24, 2017 · Past); Whitehawk Therapeutics, Inc. (Director · Mar 15, 2017 – Mar 15, 2017 · Past); Nabriva Therapeutics AG (Director · Dec 30, 2016 – Dec 30, 2016 · Past); Roka Bioscience Inc (Director · Sep 21, 2016 – Sep 21, 2016 · Past); Loxo Oncology Inc (Director · Aug 10, 2016 – Dec 8, 2017 · Past); Cartesian Therapeutics, Inc. (Director · Jun 21, 2016 – Jun 27, 2016 · Past); Corvus Pharmaceuticals, Inc. (Director · May 18, 2016 – Jun 23, 2016 · Past); Intellia Therapeutics, Inc. (Director · May 11, 2016 – May 11, 2016 · Past); Adaptimmune Therapeutics PLC (Director · Jan 1, 2016 – Mar 27, 2017 · Past); Otonomy Inc (Director · Nov 17, 2015 – Nov 25, 2015 · Past); Dimension Therapeutics (Director · Oct 27, 2015 – Oct 27, 2015 · Past); Sierra Oncology Inc (Director · Jul 15, 2015 – Jul 21, 2015 · Past); Palvella Therapeutics, Inc. (Director · Jun 29, 2015 – Jul 6, 2015 · Past); Glaukos Corporation (Director · Jun 24, 2015 – Aug 31, 2017 · Past); Intercept Pharmaceuticals Inc (Director · Apr 9, 2013 – Jul 17, 2015 · Past); Supernus Pharmaceuticals, Inc. (Director · May 4, 2012 – May 4, 2012 · Past); Anthera Pharmaceuticals Inc (Director · May 9, 2011 – Jan 30, 2013 · Past); Amarin Corporation plc (Director · Jan 1, 2011 – Sep 4, 2012 · Past); NxStage Medical Inc (Director · Jul 23, 2008 – Dec 9, 2010 · Past); Albireo Pharma Inc (Director · Feb 12, 2008 – Jun 9, 2009 · Past); Aryx Therapeutics Inc (Director · Nov 7, 2007 – Nov 13, 2007 · Past); Insulet Corporation (Director · May 14, 2007 – May 14, 2007 · Past); Volcano Corp (Director · Jun 14, 2006 – Jun 20, 2006 · Past); Given Imaging Ltd (Director · May 24, 2006 – May 24, 2006 · Past); Avanir Pharmaceuticals Inc (Director · Feb 13, 2006 – May 31, 2006 · Past)
Director · Jul 19, 2016 – Jul 19, 2016 · Past
Jennifer Jarrett
Other companies: Damora Therapeutics, Inc. (President and Chief Executive Officer in March 2026, Board Director · Since at least Mar 30, 2026); Sagimet Biosciences Inc. - Series A (Board Member · Since at least Aug 1, 2024); Zura Bio Limited (Director · Since at least Mar 20, 2023); Syndax Pharmaceuticals, Inc. (Director · Since at least Sep 25, 2018); Arcus Biosciences, Inc. (Chief Operating Officer · Since at least Mar 14, 2018); Radius Health, Inc. (Director · May 18, 2022 – Aug 15, 2022 · Past); Surrozen, Inc. (Director · Nov 18, 2020 – Nov 18, 2020 · Past); Arena Pharmaceuticals Inc (Director · Jun 13, 2017 – Mar 11, 2022 · Past); Medivation Inc (Chief Financial Officer · Apr 7, 2016 – Sep 28, 2016 · Past)
Director · Jun 12, 2017 – Jan 15, 2020 · Past
Kush M. Parmar
Other companies: Entrada Therapeutics, Inc. (Managing Partner, 5am Ventures (Board Chairman) · Since at least Oct 28, 2021); Rallybio Corporation (Director · Jul 28, 2021 – May 15, 2024 · Past); Vor Biopharma Inc. (Director · Feb 4, 2021 – Jun 14, 2022 · Past); 5 01 Acquisition Corp (Co-CEO, Director · Oct 13, 2020 – Nov 30, 2020 · Past); Akouos Inc (Director · Jun 25, 2020 – Nov 30, 2022 · Past); Arvinas, Inc. (Director · Sep 26, 2018 – Sep 24, 2019 · Past); Q32 Bio Inc. (Director · Mar 27, 2018 – Jun 15, 2022 · Past); Scpharmaceuticals Inc (Director · Nov 16, 2017 – Jun 19, 2018 · Past)
Director · Jul 19, 2016 – Jun 8, 2018 · Past
Natalie Holles
Other companies: LeonaBio, Inc. (Board Member | Chief Executive Officer · Since at least May 5, 2026); Aura Biosciences, Inc. (Chief Executive Officer and President and member of the Board · Since at least Apr 30, 2026); Third Harmonic Bio Inc. (CEO, Director · Since at least Sep 14, 2022); Day One Biopharmaceuticals Inc (Director · Since at least May 26, 2021); Allakos Inc (Director · Dec 21, 2020 – May 25, 2021 · Past); Rubius Therapeutics Inc (Director · Mar 19, 2019 – May 12, 2022 · Past); Hyperion Therapeutics Inc (SVP, Business Development · Jun 24, 2013 – May 7, 2015 · Past)
President and COO · Jul 19, 2016 – Jan 15, 2020 · Past
Mark Alan Goldberg
Other companies: Blueprint Medicines Corp (Director · Since at least Jun 25, 2015); aTyr Pharma, Inc. (Director · May 6, 2015 – May 9, 2017 · Past); Crescent Biopharma, Inc. (Director · Jul 8, 2014 – May 1, 2024 · Past); Aceragen Inc. (Director · Jan 7, 2014 – Jun 23, 2022 · Past); ImmunoGen Inc (Director · Nov 8, 2011 – Feb 12, 2024 · Past); Synageva BioPharma Corp (EVP, Medical & Reg. Strategy · Nov 2, 2011 – Sep 19, 2014 · Past)
Director · Dec 11, 2017 – Jan 15, 2020 · Past
Scott Morrison
Other companies: Tarsus Pharmaceuticals, Inc. (Director · Since at least Oct 6, 2022); Zai Lab Ltd. (Board Member · Since at least Oct 13, 2021); Vera Therapeutics, Inc. (Director · Since at least May 13, 2021); IDEAYA Biosciences, Inc. (Director | Partner, Ernst & Young (retired) · Since at least May 22, 2019); Corvus Pharmaceuticals, Inc. (Director · Since at least Mar 22, 2016); Global Blood Therapeutics Inc (Director · Jan 1, 2016 – Oct 5, 2022 · Past)
Director · Jul 19, 2016 – Jan 15, 2020 · Past
Thomas Woiwode
Other companies: Tempest Therapeutics, Inc. (Director · Jun 25, 2021 – Jun 17, 2022 · Past); Aligos Therapeutics, Inc. (Director · Oct 15, 2020 – Jun 23, 2022 · Past); Passage Bio, Inc. (Director · Feb 27, 2020 – May 25, 2023 · Past); Gritstone bio, Inc. (Director · Sep 27, 2018 – Aug 25, 2021 · Past); CRISPR Therapeutics AG (Director · Oct 18, 2016 – Jun 15, 2018 · Past); Adverum Biotechnologies Inc (Director · May 11, 2016 – May 12, 2021 · Past)
Director · Jul 19, 2016 – Aug 24, 2016 · Past
Edward R. Conner
Other companies: Jade Biosciences, Inc. (Chief Medical Officer · Since Apr 22, 2026); Ardelyx, Inc. (Chief Medical Officer · Since at least Aug 1, 2025); Third Harmonic Bio Inc. (Chief Medical Officer · Sep 14, 2022 – Jan 15, 2025 · Past); Enliven Therapeutics, Inc. (Director · Apr 22, 2020 – Jun 2, 2022 · Past); Sangamo Therapeutics, Inc. (Sr. VP & Chief Medical Officer · Nov 30, 2016 – Jan 24, 2019 · Past)
SVP, Chief Medical Officer · Jul 15, 2019 – Jan 15, 2020 · Past
Louis G Lange
Other companies: NewAmsterdam Pharma Company N.V. (Director · Since at least Dec 29, 2023); Epiphany Technology Acquisition Corp (Director · Sep 16, 2022 – Sep 16, 2022 · Past); BioPlus Acquisition Corp (Director · Dec 2, 2021 – Dec 2, 2021 · Past); Esperion Therapeutics, Inc. (Director · Jun 25, 2013 – Jul 1, 2013 · Past); Maxygen Inc (Director · May 27, 2010 – Jun 6, 2012 · Past)
Director · Jul 19, 2016 – Jan 15, 2020 · Past
Stephen P Squinto
Other companies: Chemomab Therapeutics Ltd. (Director · Mar 16, 2021 – Apr 19, 2021 · Past); Compass Therapeutics, Inc. (Director · Jun 17, 2020 – Feb 18, 2022 · Past); Passage Bio, Inc. (Head of Research and Dev, Director · Feb 27, 2020 – Feb 27, 2020 · Past); SpringWorks Therapeutics Inc (Director · Mar 29, 2019 – May 19, 2022 · Past); Alexion Pharmaceuticals Inc (EVP, Chief Global Ops. Officer · Jan 9, 2006 – Oct 27, 2014 · Past)
Director · Jul 19, 2016 – Oct 8, 2017 · Past
All 19 people
PersonSeat
Julie Anne Smith
Other companies: Stoke Therapeutics, Inc. (Director · Since at least Jun 3, 2020); Exelixis, Inc. (Director · Since at least Sep 22, 2016); Raptor Pharmaceutical Corp (President and CEO, Director · Sep 10, 2012 – Oct 24, 2016 · Past)
Director · Dec 12, 2016 – Jan 15, 2020 · Past
Matthew R Patterson
Other companies: Vor Biopharma Inc. (Director · Feb 4, 2021 – May 22, 2025 · Past); 5 01 Acquisition Corp (Director · Oct 13, 2020 – Oct 16, 2020 · Past); Q32 Bio Inc. (Director · Mar 27, 2018 – Jun 14, 2023 · Past)
Chief Executive Officer, Director · Jul 19, 2016 – Jan 15, 2020 · Past
Thomas P Soloway
Other companies: Third Harmonic Bio Inc. (Director · Since at least Sep 14, 2022); Satsuma Pharmaceuticals Inc (Director · Jul 2, 2020 – Jun 8, 2023 · Past); Paratek Pharmaceuticals Inc (EVP, Chief Operating Officer · Jan 30, 2009 – Jul 15, 2013 · Past)
Executive Vice President, CFO · Jul 19, 2016 – Jan 15, 2020 · Past
Mark Meltz
Other companies: Lyell Immunopharma, Inc. (General Counsel and Corporate Secretary · Since at least Jun 9, 2025); Kinnate Biopharma Inc (COO GENERAL COUNSEL SECRETARY · Dec 2, 2020 – Apr 3, 2024 · Past)
SVP, General Counsel · Mar 28, 2019 – Jan 15, 2020 · Past
Thomas J. Schuetz
Other companies: Compass Therapeutics, Inc. (Chief Executive Officer, Compass Therapeutics · Since at least Jun 17, 2020); Relypsa Inc (Director · Nov 14, 2013 – Sep 1, 2016 · Past)
Director · Jul 19, 2016 – Jan 15, 2020 · Past
David Nagler
Other companies: Aryx Therapeutics Inc (V.P.,Corp. Affairs & Sect. · Nov 7, 2007 – Feb 25, 2010 · Past)
SVP, HR & Corp. Affairs · Jul 19, 2016 – Jun 20, 2018 · Past
Suyash Prasad
Other companies: Taysha Gene Therapies, Inc. (CMO and Head of R&D · Sep 23, 2020 – Jul 5, 2022 · Past)
Senior VP & Chief Med Officer · Jul 19, 2016 – Jun 5, 2019 · Past
John T GraySVP, Chief Scientific Officer · Jul 19, 2016 – Sep 28, 2018 · Past
Mary NewmanSVP, Regulatory Affairs · Jul 19, 2016 – Nov 15, 2018 · Past

Open People

Log in to ask 6ix AI your own questions about Audentes Therapeutics Inc.